The DOK7 gene helps build and maintain the place where nerves tell muscles to move. This gene plays an important role in keeping those signals steady so muscles can contract normally. If the DOK7 gene does not work properly, the signal from nerve to muscle can be too weak, which can lead to a type of congenital myasthenic syndrome. People with disease-causing variants in the DOK7 gene may have muscle weakness, get tired easily, and find climbing stairs, lifting, or sometimes breathing more difficult.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to make proteins, which are the working parts of cells. Other genes mainly control when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. More on this topic is available in the LearnHub.
Overview
DOK7Gene function
What if the gene works
The DOK7 gene helps build and maintain the point where nerves signal muscles. This supports normal muscle activation and movement.
Risk
What if the gene does not work
Variants in the DOK7 gene can cause congenital myasthenic syndrome, with muscle weakness often affecting the hips, shoulders, and breathing muscles. Milder or more severe variants can influence when symptoms begin and how much weakness occurs.
Treatment
What does that mean for your treatment
Pathogenic variants in the DOK7 gene often guide treatment toward salbutamol (albuterol) or ephedrine, which can improve muscle strength and stamina. Medicines that boost nerve to muscle signaling, such as pyridostigmine, often help little and may worsen weakness in this setting.
Conditions associated with DOK7
Gene function
What if the gene works
Each time you move, your muscles need a clear handoff from nerve to muscle. The DOK7 gene helps set up and support the neuromuscular junction, the contact point where a nerve tells a muscle to contract. When it works properly, this signal system stays organized and responsive.
Inside muscle cells, this gene helps switch on the MUSK protein, a signal receiver that starts building the nerve-muscle contact point. This early step helps place the junction in the right spot.
It helps gather acetylcholine receptors, the muscle's signal catchers, into tight groups at the neuromuscular junction. This helps nerve to muscle communication stay clear and efficient.
One of its main roles is to support the growth and shaping of the motor endplate, the specialized muscle surface at this junction. This gives the nerve ending an organized place to deliver its message.
After the junction forms, this gene helps keep its structure stable. That steady support helps everyday muscle signals pass reliably during movement.
What is a variant?
A genetic variant is a slight change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more significantly change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
DNA changes in the DOK7 gene can weaken how the DOK7 protein is made, how stable it is, or how well it signals with the MUSK protein at the connection between nerve and muscle. In people looking into how DOK7 gene variants affect protein function, milder variants may leave some signaling intact, while more severe variants can greatly reduce or stop activity, often by creating a shortened protein. This range can influence how early congenital myasthenic syndrome starts and how marked it becomes.
How variants are linked to conditions
Pathogenic variants in both copies of the DOK7 gene cause DOK7-related congenital myasthenic syndrome. In DOK7 gene variants and congenital myasthenic syndrome, the usual pattern is muscle weakness that often affects the hips, shoulders, and breathing muscles, with symptoms starting in childhood or sometimes later. This is the main condition firmly linked to the DOK7 gene in human genetics.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DOK7, risk is mainly shaped by inheritance rather than lifestyle. A child’s chance of having a DOK7-related muscle weakness condition is much higher when both biological parents carry a harmful DOK7 change. There is not broadly confirmed evidence that diet, exercise, or everyday habits meaningfully change this genetic risk.
Inheritance of DOK7 variants
DOK7-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops a DOK7-related congenital myasthenic syndrome only when they inherit two disease-causing variants in the DOK7 gene, one from each parent. Parents who each carry one variant are typically healthy carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial DOK7 variant. For families asking how variants of the DOK7 gene are inherited, sons and daughters are affected equally because DOK7 is on chromosome 4, which is an autosome.
What does my DOK7 result mean for my family?
A DOK7 result linked to disease usually has family meaning in a recessive pattern. This often means parents are healthy carriers, and brothers or sisters may also be carriers or, less often, have the condition. Other relatives on either side of the family may carry the same gene change too, especially if there is a family history of similar muscle weakness or breathing problems in infancy or childhood.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the DOK7 gene usually uses a blood or saliva sample, which a lab reads to look for spelling changes in the DNA. DOK7 genetic testing can show whether you carry a disease-causing variant and may be done as single-gene testing, as part of a neuromuscular panel, or through broader sequencing.
When should I consider getting a genetic test?
Consider DOK7 genetic testing if you or your child has ongoing muscle weakness that gets worse with activity, droopy eyelids, breathing or feeding problems, or a diagnosis of an inherited condition that affects how nerves signal muscles. Testing may also help when a close relative has a known change in the DOK7 gene.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals depends on both the condition and the kind of variant involved. Factors like lifestyle, environment, age, and medical history all influence how the body functions over time. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else. These differences are common and are one part of why treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that looks at how genetic differences can shape a person’s response to medications. It examines connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect either how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the DOK7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines, side effects, or new symptoms are best discussed with your doctor.